Magna Ease Versus Trifecta Early Hemodynamics: A Systematic Review and Meta-analysis

Objective This meta-analysis compares the early echocardiographic outcomes of aortic valve replacement using the two most commonly implanted stented bioprostheses. Methods We searched MEDLINE and EMBASE databases until 2017 for studies comparing Magna or Magna Ease (Edwards Lifesciences, Irvine, CA USA) versus Trifecta (St Jude Medical, St. Paul, MN USA) aortic bioprosthetic valves. A random-effects meta-analysis was performed for the primary outcome of mean gradient on echocardiography and secondary outcomes of effective orifice area, indexed effective orifice area, and in-hospital mortality. Results There were two randomized controlled trial, three matched, and six unmatched retrospective observational studies with 2119 patients [median reported follow-up = 6 months (interquartile range = 6 to 12)]. The Magna/Magna Ease valve was associated with higher early mean gradient (mean difference = 4.09, 95% confidence interval = 3.48 to 4.69, P
Source: Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery - Category: Cardiovascular & Thoracic Surgery Tags: Original Articles Source Type: research

Related Links:

CONCLUSIONS: The incidence and risk factor associations for AKI post TAVR vary by definitions used. Decreased GFR at baseline by both MDRD and CKD-EPI and non-transfemoral approach were associated with an increased risk of AKI post TAVR. PMID: 31941833 [PubMed - as supplied by publisher]
Source: The Journal of Invasive Cardiology - Category: Cardiology Tags: J Invasive Cardiol Source Type: research
ConclusionsMinimally invasive reoperative AVR with a sutureless or rapid-deployment prosthesis is a safe and feasible treatment strategy, resulting in fast recovery and improved postoperative outcome with no mortality and an acceptable complication rate.
Source: The Annals of Thoracic Surgery - Category: Cardiovascular & Thoracic Surgery Source Type: research
Publication date: Available online 15 January 2020Source: The Annals of Thoracic SurgeryAuthor(s): Yuting Chiang
Source: The Annals of Thoracic Surgery - Category: Cardiovascular & Thoracic Surgery Source Type: research
Cardiorenal syndrome (CRS) is a group of pathophysiological disorders affecting heart and kidneys.
Source: BMC Cardiovascular Disorders - Category: Cardiology Authors: Tags: Case report Source Type: research
PERCUTANEOUS REPAIR and replacement increasingly are being used to treat valvular heart disease. Adoption of these catheter-based techniques necessitates standardized methods for evaluating new or residual regurgitation after percutaneous valve repair or replacement. The American Society of Echocardiography guidelines document, “Guidelines for the Evaluation of Valvular Regurgitation After Percutaneous Valve Repair or Replacement,” addresses this need and provides a framework for evaluating regurgitation using echocardiography, invasive hemodynamic assessment, and cardiac magnetic resonance (CMR) imaging.
Source: Journal of Cardiothoracic and Vascular Anesthesia - Category: Anesthesiology Authors: Tags: Review Article Source Type: research
This summarizes the incidence of septo-octogenarian patients in our robotic mitral experience and provides comparative outcomes to STS predicted models of mortality, stroke, and shortened length of stay, demonstrating that elderly patients ( ≥70 years) matched STS benchmarks and outperforming STS predicted short length of stay in this study population. NYHA = New York Heart Association. PCI = percutaneous coronary intervention. LOS = length of stay. STS = Society of Thoracic Surgeons.Advanced age confers higher STS pre dicted risks of mortality (PROM) and longer hospital lengths of stay (LOS) in patients...
Source: Seminars in Thoracic and Cardiovascular Surgery - Category: Cardiovascular & Thoracic Surgery Authors: Tags: ADULT – Original Submission Source Type: research
Personalized medicine is nowadays considered as the next disruptive evolution in the treatment of cardiovascular diseases, which remain the leading cause of mortality in the world [1]. Over the recent years, research has focused mainly on gene or cellular therapies [2]. In parallel, major developments have been made on trans-catheter implantable devices, such as coronary and peripheral stents, aortic valves and stent-grafts, which represent an increasing part of the cardiovascular therapeutic armamentarium.
Source: International Journal of Cardiology - Category: Cardiology Authors: Tags: Editorial Source Type: research
AbstractUnderexpansion of transcatheter heart valves and the surgically implanted Perceval sutureless aortic valve bioprosthesis has been suggested as an underlying mechanism for hypo-attenuated leaflet thickening (HALT). This was a single-center prospective observational study that included 47 patients who underwent surgical aortic valve replacement with the Perceval sutureless bioprosthesis (LivaNova, London, United Kingdom) from 2012 to 2016 and were studied by four-dimensional cardiac computed tomography (CT). The association between overall and regional expansion and the prevalence of HALT was analyzed. In total 46 pa...
Source: Heart and Vessels - Category: Cardiology Source Type: research
Conclusions: The postoperative hs-TnT can be used to predict a postoperative cardiogenic shock requiring mechanical circulatory support.
Source: Shock - Category: Emergency Medicine Tags: Clinical Science Aspects Source Type: research
CONCLUSIONS: CAVI did not result in a superior functional outcome compared to OMT. Due to an unexpectedly high rate of valve dislocations, the study was stopped for safety reasons. PMID: 31929100 [PubMed - as supplied by publisher]
Source: EuroIntervention - Category: Cardiovascular & Thoracic Surgery Tags: EuroIntervention Source Type: research
More News: Cardiology | Databases & Libraries | Heart | Heart Valve Surgery | Hospitals | Study